We are live on ! Find out more
WX

WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX

Delisted

WX was delisted on the 10th of December, 2015.

157 hedge funds and large institutions have $2B invested in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in 2014 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 65 increasing their positions, 42 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 42

16% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 19

2% more funds holding

Funds holding: 154157 (+3)

5% more capital invested

Capital invested by funds: $1.91B → $2B (+$90M)

33% less funds holding in top 10

Funds holding in top 10: 64 (-2)

45% less call options, than puts

Call options by funds: $1.31M | Put options by funds: $2.36M

Holders
157
Holders Change
+3
Holders Change %
+1.95%
% of All Funds
4.56%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.12%
New
22
Increased
65
Reduced
42
Closed
19
Calls
$1.31M
Puts
$2.36M
Net Calls
-$1.06M
Net Calls Change
-$3.01M
Name Holding Trade Value Shares
Change
Change in
Stake
GPCM
76
Granite Point Capital Management
Massachusetts
$2.45M
State of New Jersey Common Pension Fund D
77
State of New Jersey Common Pension Fund D
New Jersey
$2.16M
KCM
78
Kornitzer Capital Management
Kansas
$2.16M
PP
79
PDT Partners
New York
$2.11M +$2.06M +60,171 New
Bank of Montreal
80
Bank of Montreal
Ontario, Canada
$2.09M +$76.5K +2,231 +4%
GI
81
GAMCO Investors
Connecticut
$2M
Northern Trust
82
Northern Trust
Illinois
$2M +$843K +24,608 +76%
Janus Henderson Group
83
Janus Henderson Group
United Kingdom
$1.89M +$1.85M +53,996 New
BCM
84
Brown Capital Management
Maryland
$1.86M
HighTower Advisors
85
HighTower Advisors
Illinois
$1.79M +$221K +6,449 +14%
Goldman Sachs
86
Goldman Sachs
New York
$1.62M +$1.27M +37,043 +399%
ERSOT
87
Employees Retirement System of Texas
Texas
$1.58M -$1.14M -33,400 -43%
NFA
88
Nationwide Fund Advisors
Ohio
$1.47M +$1.44M +42,040 New
RFC
89
Regions Financial Corp
Alabama
$1.47M +$184K +5,366 +15%
GT
90
Glenmede Trust
Pennsylvania
$1.45M
GCP
91
GSA Capital Partners
United Kingdom
$1.39M +$322K +9,400 +31%
LMGAM
92
Liberty Mutual Group Asset Management
Massachusetts
$1.3M
WBC
93
Westpac Banking Corp
Australia
$1.27M +$223K +6,499 +22%
QBFM
94
QS Batterymarch Financial Management
New York
$1.24M
Lazard Asset Management
95
Lazard Asset Management
New York
$1.22M +$1.19M +34,673 +17,337%
PA
96
Profund Advisors
Maryland
$1.19M +$118K +3,457 +11%
HI
97
HBK Investments
Texas
$1.14M +$234K +6,822 +27%
PRCM
98
Pine River Capital Management
Minnesota
$1.12M
BHTS
99
Bar Harbor Trust Services
Maine
$1.08M +$1.06M +30,925 New
Allianz Asset Management
100
Allianz Asset Management
Germany
$1.07M +$405K +11,801 +63%

WX Hedge Fund Activity: Q3 2014 in Review

157 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) for Q3 2014, worth a combined $2B — up 4.7% from $1.91B a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new WX positions and 19 closed out — a net gain of 3 holders — while 65 added to existing stakes and 42 trimmed.

The largest buyer was Fidelity International, adding an estimated $55.5M. The largest seller was Mirae Asset Global Investments, cutting an estimated $63.6M.

  • 157 institutional investors held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) as of Q3 2014, up from 154 in Q2 2014.
  • Funds reported $2B of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS stock for Q3 2014, up 4.7% quarter-over-quarter.
  • 22 funds opened new WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS positions in Q3 2014 and 19 closed out, a net change of +3 holders.
  • The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS buyer in Q3 2014 was Fidelity International, an estimated $55.5M added.
  • The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS seller in Q3 2014 was Mirae Asset Global Investments, an estimated $63.6M sold.

Based on aggregated 13F filings for Q3 2014.